142 related articles for article (PubMed ID: 24530772)
1. Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes.
Liu JJ; Liu S; Morgenthaler NG; Wong MDS; Tavintharan S; Sum CF; Lim SC
Atherosclerosis; 2014 Apr; 233(2):415-418. PubMed ID: 24530772
[TBL] [Abstract][Full Text] [Related]
2. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.
van Ark J; Hammes HP; van Dijk MC; Lexis CP; van der Horst IC; Zeebregts CJ; Vervloet MG; Wolffenbuttel BH; van Goor H; Hillebrands JL
Cardiovasc Diabetol; 2013 Aug; 12():116. PubMed ID: 23945089
[TBL] [Abstract][Full Text] [Related]
3. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
4. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes.
Fountoulakis N; Maltese G; Gnudi L; Karalliedde J
J Clin Endocrinol Metab; 2018 May; 103(5):2026-2032. PubMed ID: 29509906
[TBL] [Abstract][Full Text] [Related]
5. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications.
Zhang L; Liu T
J Diabetes Complications; 2018 Oct; 32(10):922-930. PubMed ID: 30042059
[TBL] [Abstract][Full Text] [Related]
7. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
8. Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.
Lee EY; Kim SS; Lee JS; Kim IJ; Song SH; Cha SK; Park KS; Kang JS; Chung CH
PLoS One; 2014; 9(8):e102984. PubMed ID: 25084095
[TBL] [Abstract][Full Text] [Related]
9. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
10. Soluble Klotho Is Decreased in Children With Type 1 Diabetes and Correlated With Metabolic Control.
Zubkiewicz-Kucharska A; Wikiera B; Noczyńska A
Front Endocrinol (Lausanne); 2021; 12():709564. PubMed ID: 34603200
[TBL] [Abstract][Full Text] [Related]
11. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
12. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children.
Zhang Y; Li G; Xiao F; Wang B; Li J; Jia X; Sun Y; Chen H
BMC Pediatr; 2023 Mar; 23(1):120. PubMed ID: 36927328
[TBL] [Abstract][Full Text] [Related]
14. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.
Karalliedde J; Maltese G; Hill B; Viberti G; Gnudi L
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1899-905. PubMed ID: 23929932
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy.
Kamoi K; Ishibashi M; Yamaji T
Diabetes Res Clin Pract; 1994 Jul; 24(3):125-9. PubMed ID: 7988343
[TBL] [Abstract][Full Text] [Related]
16. Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
Dhaun N; Yuzugulen J; Kimmitt RA; Wood EG; Chariyavilaskul P; MacIntyre IM; Goddard J; Webb DJ; Corder R
J Am Heart Assoc; 2015 Mar; 4(3):e001624. PubMed ID: 25801761
[TBL] [Abstract][Full Text] [Related]
17. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
[TBL] [Abstract][Full Text] [Related]
18. Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.
Habib A; Al-Omari MA; Khaleghi M; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Turner ST; Kullo IJ
Am J Hypertens; 2010 Nov; 23(11):1204-8. PubMed ID: 20634796
[TBL] [Abstract][Full Text] [Related]
19. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy.
Dogan B; Arikan IH; Guler D; Keles N; Isbilen B; Isman F; Oguz A
Int Urol Nephrol; 2016 Mar; 48(3):399-407. PubMed ID: 26759325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
